about
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM).Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells.CAR T-cell immunotherapy of MET-expressing malignant mesothelioma.Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.Luminol Chemiluminescence Reports Photodynamic Therapy-Generated Neutrophil Activity In Vivo and Serves as a Biomarker of Therapeutic EfficacyA preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy.Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung CancerLoss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosisPhenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes
P50
Q38399051-BFB12A74-673A-4BA0-B6A8-84C8B595BB45Q38715459-A96E299C-D5C1-4591-8D08-C13283D56AAAQ47280088-86DD6F9E-A0DF-45EC-8B29-09A2ACDEC04BQ48254799-DE040B25-D6EC-466E-8A98-DF4910D4F598Q57788536-A3D6C3AE-ACC3-4934-A2E1-DD5A1C933D32Q64973042-72DBBBA4-5C6E-472D-AC3F-7528D0211FB6Q91750602-89AAF4E7-9BD1-4404-8BD4-1C3382402134Q92678774-DC431DB3-D00C-4751-8D9A-5CBF4859DD04Q92715370-136F7E4C-92A2-47D4-86B7-1E9FC820ED24
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0572-502X
@en
name
Astero Klampatsa
@ast
Astero Klampatsa
@en
Astero Klampatsa
@es
Astero Klampatsa
@nl
type
label
Astero Klampatsa
@ast
Astero Klampatsa
@en
Astero Klampatsa
@es
Astero Klampatsa
@nl
prefLabel
Astero Klampatsa
@ast
Astero Klampatsa
@en
Astero Klampatsa
@es
Astero Klampatsa
@nl
P106
P31
P496
0000-0003-0572-502X